The possibility that the Covid-19 crisis will worsen considerably due to Omicron is something that I as a UK share investor need to consider carefully.
I’m not just thinking about how my stocks portfolio could suffer in the short-to-medium term, however. I’m looking at stocks that I could buy to help offset weakness elsewhere. There are plenty of UK shares for me to buy whose services should remain in strong demand if the public health emergency persists. Here are two top stocks I’d buy if the battle against the pandemic begins to look shaky.
Abingdon Health
Penny stock Abingdon Health (LSE: ABDX) makes rapid lateral flow tests that diagnose whether or not an individual has contracted Covid-19. It therefore serves an essential role in helping prevent the spread of the virus and in keeping the world turning during the pandemic.
Abingdon launched its BioSURE Covid-19 IgG Antibody Self Test over the summer, a kit that can detect infection from a drop of blood within 20 minutes. The company has embarked on massive investment at its manufacturing sites in York and Doncaster to meet strong demand. It also makes other medical products to detect infection. And more recently it has been undertaking work that could see it mass produce antigen tests for Avacta and Vatic Health. All this bodes well for future revenues.
The marketplace for coronavirus testing kits is huge, sure. And a high-profile failure of its testing kits could prove catastrophic for future business wins. But I’m encouraged by the reliability of Abingdon’s technologies so far and think its huge investment programme could deliver mighty returns for its shareholders.
Bunzl
Support services firm Bunzl (LSE: BNZL) is the perfect pick for me in uncertain times like these, I feel. It sells a huge range of essential products and services to a variety of end markets across the globe. This allows profits to remain stable during the good times and the bad. And so it could be the perfect pick as the Omicron variant threatens the global economic recovery.
This strength-through-diversification is the reason I added the FTSE 100 firm to my shares portfolio several years back. But this isn’t the only reason I’m considering adding to my holdings today. This is because Bunzl’s revenues have actually risen as a direct result of Covid-19. Turnover rose 9.4% year-on-year in 2020 as demand for its masks, gloves, disinfectants and other protective products soared.
Bunzl shares trade on a P/E ratio just above 19 times for 2022. I think such a premium valuation is deserved given its long-term record of growing annual profits, whatever the weather. I plan to hold my Bunzl shares for a long time. That’s even though poor execution of its acquisition-led growth strategy creates notable risks. Failures on this front could have a particularly serious impact if they forced the firm to dial back its ambitious M&A drive.
5 Stocks For Trying To Build Wealth After 50
Markets around the world are reeling from the coronavirus pandemic…
And with so many great companies still trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.
But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.
Fortunately, The Motley Fool is here to help: our UK Chief Investment Officer and his analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global lock-down…
You see, here at The Motley Fool we don’t believe “over-trading” is the right path to financial freedom in retirement; instead, we advocate buying and holding (for AT LEAST three to five years) 15 or more quality companies, with shareholder-focused management teams at the helm.
That’s why we’re sharing the names of all five of these companies in a special investing report that you can download today for FREE. If you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio, and that you can consider building a position in all five right away.
Click here to claim your free copy of this special investing report now!
Royston Wild owns shares of Bunzl. The Motley Fool UK has recommended Bunzl. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
This post was originally published on Motley Fool
